Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
about
Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver diseaseAntifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver diseaseOutcomes of abdominal surgery in patients with liver cirrhosisCoagulopathy in liver disease: Lack of an assessment toolChanging Concepts of Cirrhotic Coagulopathy.Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.Dismantling the myth of "autoanticoagulation" in cirrhosis: an old dogma dies hard.Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.Nontransfusional approach to increased platelet count in patients with cirrhosis and thrombocytopenia.Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis.Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosisThrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation.Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.Venous Thromboembolism in Patients With Thrombocytopenia: Risk Factors, Treatment, and Outcome.Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding riskPerioperative Care of Patients With Liver Cirrhosis: A Review.Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation.Liver disease, coagulopathies and transfusion therapyClinical utility of viscoelastic tests of coagulation in patients with liver disease.The emerging roles of microvesicles in liver diseases.Big spleens and hypersplenism: fix it or forget it?The coagulation system in patients with end-stage liver disease.Managing complications in cirrhotic patientsInfluence of cirrhosis in cardiac surgery outcomes.Gastrointestinal endoscopy in the cirrhotic patient.A conceptual and practical approach to haemostasis in paediatric liver disease.Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasms Is Feasible and Not Riskier for Patients with Liver Cirrhosis.Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C.Low-grade endotoxemia and platelet activation in cirrhosis.Correlation between platelet count and both liver fibrosis and spleen diameter in patients with schistosomiasis mansoni.Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis.Occult liver disease burden: Analysis from a large general practitioners' database.Viscoelastic Monitoring to Guide Hemostatic Resuscitation in Liver Transplantation Surgery.Transfemoral Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease in Child's Class C Liver Disease Prior to Orthotopic Liver Transplantation: A Case Report.Biology of portal hypertension.Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis.Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.Platelets as Modulators of Liver Diseases.Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics.Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure
P2860
Q24187246-B6903079-9C81-411C-8C69-4431C452AF0CQ24200420-22687795-9B20-4C53-9338-ADEEC4DC9A0EQ26766070-3DB1F645-BD89-4F25-B2E0-3D2C3107E4F7Q26781714-C8B94EBB-1E45-4F66-B1E5-3AFBE1D43CB1Q30275544-EA6A42C4-6B7F-4DCD-8EBA-A5414C5CBB00Q30277075-E6E07DAC-8B5B-4214-B592-2048F89B4AC6Q30455384-9A054D69-F022-4033-9947-FACE0FCECBE5Q33404773-2691201B-5EDC-488C-818A-A681C0DF15E6Q33407950-42C1D74E-9523-4662-9D08-42531317C958Q33414605-5755930D-ED8B-4513-8770-94499972DB36Q33418710-1121D02C-E036-4DA2-8006-D33EB59224C8Q33418906-A8657E20-D62E-4326-B141-94E09BE0AA32Q33427048-503A8CDE-AAD4-401E-A1E6-8421CC39A2DEQ33427150-A41C2542-DD84-4A77-A118-BEE80D898F6BQ33440126-18B67BA2-D785-4FDE-AC0D-DD152D7FCD59Q33441586-6E32ECD0-0A82-4D5C-8965-B562C72B9624Q37282201-36C8AA15-5FE6-46D2-BF67-861BEBF25693Q38051476-FC6229C9-5917-43C6-896B-5EF1B7293882Q38103574-FC6D41DB-ECC4-4173-9DC1-8770290F010BQ38184831-7E1EC9FD-AA72-4FB4-BEDB-F8F34D5B6F06Q38259960-B38A08A3-4BC4-41C3-9AA8-82843D51AD45Q38295874-5AEEB50B-C1AF-4601-AF20-F53450F8EA76Q38344890-46249C10-1AF5-41E5-8FD0-4370B6F4E77AQ38443646-289898C9-DB2C-40F5-A7AD-83F23D51D512Q38476069-A49B11C7-C703-42B9-AE68-2A23225E13AEQ38788396-E948F0C6-089C-4297-B5A1-3582B9908638Q39259707-6ED906CA-309E-4162-BD78-56AAA957FD8FQ40061733-9DCB4CF8-6D32-4A3D-A434-F88F7A083F63Q40536260-D40AF0FE-E909-4D67-B517-57DF1F908175Q42222678-8011D101-BE24-4BEF-B12A-0876A0B298CEQ45883014-5EC2E291-03CF-4F17-998A-746B16C55120Q45903563-1F706C0D-B2AA-4458-B8D8-53536A174C0DQ46204737-673B8927-115B-4C0A-BEAC-E276171F03A9Q47621401-9559B0C9-0EED-4370-AD9F-FC7F94705360Q47874043-4C5B7A0C-B507-44A3-9D7F-E83E0AA338FAQ48362914-0858A346-4495-4835-BF56-D0E5BE0CF83DQ48533165-E1F9F742-666C-4BF8-9B5B-052E954266AAQ50131013-322FF78B-FB93-42C6-8453-E6C272745A77Q52445950-4AC85E68-BC69-498F-B3BC-C2BFFFB68F67Q57824692-23C6114E-1301-4260-8E6C-38282D542537
P2860
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
@ast
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
@en
type
label
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
@ast
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
@en
prefLabel
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
@ast
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
@en
P50
P1476
Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
@en
P2093
P304
P356
10.1016/J.JHEP.2011.06.008
P577
2011-06-28T00:00:00Z